A retrospective cohort of 120 amniocenteses at a regional Turkish centre found that chromosomal microarray and exome ...

Illumina (NASDAQ:ILMN) reported third-quarter results above its prior guidance, citing strong clinical sequencing demand, elevated NovaSeq X instrument placements and disciplined spending. The company ...

Evaluate the expected performance of Illumina (ILMN) for the quarter ended September 2026, looking beyond the conventional ...

<?xml encoding="utf-8" ?> Illumina ILMN reported third-quarter financial results on Thursday. The transcript from the company ...

Guidance shifted upward again, with Q3 raising full-year 2026 revenue to $4.64 billion to $4.66 billion and EPS to $5.40 to $5.45, following Q2’s earlier raise (Q2 guided $4.60 billion to $4.64 ...

Genome sequencing of two siblings with adult-onset leukodystrophy uncovered a novel 270 kb deletion upstream of LMNB1 that ...

Illumina launched its BioInsight platform, integrating analysis tools, AI models, and curated biological data to accelerate insights. The company highlighted its SpliceAI2 model, which identified 17% ...

Tumor-infiltrating B cells may reveal naturally selected antibodies and new immunotherapy targets, offering a potential path ...

Illumina reported 7.6% Q3 2026 revenue growth excluding tariff refunds and forecast full-year sales of $4.64 billion to $4.66 ...

Newswise Latest News: up-to-the-minute news, press releases, and expert sources for journalists in science, health, medicine, ...

OGT introduces first fusion MRD NGS Panel for AML to expand fusion detection at MRD-level sensitivity: Oxford, UK Tuesday, October 27, 2026, 16:00 Hrs [IST] OGT, a leading global ...

Best DNA testing kits for uncovering your family history - Use a DNA kit to discover more about your genetic make-up or where ...